Prostate Cancer - Results from #20020

Active surveillance of low risk prostate cancer - Abstract August 1, 2014

Temporal patterns of late bowel and bladder radiotherapy toxicity in a randomised controlled trial assessing duration of neo-adjuvant hormones in prostate cancer - Abstract July 31, 2014

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife - Abstract July 31, 2014

Risk of prostate cancer in patients with schizophrenia - Abstract July 31, 2014

Incidence of needle tract seeding following prostate biopsy for suspected cancer - review of the literature - Abstract July 31, 2014

The impact of robotic surgery on the surgical management of prostate cancer in the United States - Abstract July 31, 2014

Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer - Abstract July 31, 2014

Ultrasound-planned high-dose-rate prostate brachytherapy: Dose painting to the dominant intraprostatic lesion - Abstract July 31, 2014

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T - Abstract July 31, 2014

Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly - Abstract July 31, 2014

Docetaxel rechallenge in patients with metastatic castration-resistant prostate cancer - Abstract July 31, 2014

New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance - Abstract July 30, 2014

"All boys and men can play football": A qualitative investigation of recreational football in prostate cancer patients - Abstract July 30, 2014

High-resolution diffusion-weighted imaging of the prostate - Abstract July 30, 2014

Information gathering and technology use among low-income minority men at risk for prostate cancer - Abstract July 30, 2014

The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer - Abstract July 30, 2014

Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma - Abstract July 30, 2014

Degarelix as an intermittent androgen deprivation therapy for one or more treatment cycles in patients with prostate cancer - Abstract July 30, 2014

Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical T1c prostate cancer? - Abstract July 30, 2014

Prostate cancer in South Africa: Pathology based National Cancer Registry data (1986-2006) and mortality rates (1997-2009) - Abstract July 30, 2014

Page 1002 of 1436